US EditionInnovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions
Summary by The Billings Gazette
28 Articles
28 Articles
The Billings Gazette+27 Reposted by 27 other sources
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 12, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major…
·Billings, United States
Read Full ArticleCoverage Details
Total News Sources28
Leaning Left2Leaning Right1Center15Last UpdatedBias Distribution83% Center
Bias Distribution
- 83% of the sources are Center
83% Center
11%
C 83%
Factuality
To view factuality data please Upgrade to Premium
